G2 chromosomal radiosensitivity in fibroblasts of ataxia- telangiectasia heterozygotes and a Li-Fraumeni Syndrome patient with radioresistant cells

International Journal of Radiation Biology

Volumn 72, Issue 4, 1997, Pages 435-438

  Mitchell, E L D ^a   Scott, D ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; CASE REPORT; CELL CYCLE G2 PHASE; CELL KINETICS; FAMILIAL CANCER; FIBROBLAST; GENOME; HETEROZYGOTE; HUMAN; HUMAN CELL; IRRADIATION; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIZATION; CHROMOSOME ABERRATION; GENETICS; HUMAN CHROMOSOME; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; ULTRASTRUCTURE;

ATAXIA TELANGIECTASIA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; FIBROBLASTS; G2 PHASE; HETEROZYGOTE; HUMANS; LI-FRAUMENI SYNDROME; RADIATION TOLERANCE;

EID: 0030612895     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530097143202     Document Type: Article

References (28)

1. BIRCH, J. M., HARTLEY, L., TRICKER, K. J., PROSSER, J., CUNDIE, A., KELSEY, A. M., HARRIS, M., MORRIS JONES, P. H., BINCHY, A., CROWTHER, D., CRAFT, A. W., EDEN, O. B., EVANS, G. R., THOMPSON, E., MANN, J. R., MARTIN, J., MITCHELL, E. L. D. and SANTIBANEZ-KOREF, M. F., 1994, Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li Fraumeni families. Cancer Research, 54, 1298-1304.
2. BIRRELL, G. W. and RAMSAY, J. R., 1995, Induction of p53 protein by gamma radiation in lymphocyte lines from breast cancer and ataxia-telangiectasia patients. British Journal of Cancer, 72, 1096-1101.
3. EASTON, D. F., 1994, Cancer risks in A-T heterozygotes. International Journal of Radiation Biology, 66, 5177-5182.
4. HEIM, S. and MITELMAN, F., 1996, Cancer Cytogenetics (New York: Wiley-Liss).
5. HITTELMAN, W. N. and PANDITA, T. K., 1994, Possible role of chromatin alteration in the radiosensitivity of ataxia-telangiectasia. International Journal of Radiation Biology, 66, 109-113.
6. JONES, L. A., SCOTT, D., COWAN, R. and ROBERTS, S. A., 1995, Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. International Journal of Radiation Biology, 67, 519-528.
7. KASTAN, M. B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B. and CRAIG, R. W., 1991, Participation of the p53 protein in the cellular response to the DNA damage. Cancer Research, 51, 6304-6311.
8. LANE, D. P., 1992, p53, guardian of the genome. Nature, 358, 15-16.
9. MALKIN, D., LI, F. P., STRONG, L. C., FRAUMENI, J. F., NELSON, C. E., KIM, D. H., KASSEL, J., GRYKA, M. A., BISCHOFF, F. Z., TAINSKY, M. A. and FRIEND, S. H., 1990, Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science, 250, 1233-1238.
10. 2 ataxia-telangiectasia cells exposed to X-rays and AraA. International Journal of Radiation Biology, 55, 71-84.
11. NATARAJAN, A. T., MEIJERS, M., VAN ZEELAND, A. A. and SIMONS, J. W. I. M., 1982, Attempts to detect ataxia telangiectasia (A-T) heterozygotes by cytogenetical techniques. Cytogenetics and Cell Genetics, 33, 145-151.
12. 2-phase x irradiation in relation to DNA repair and radiosensitivity in a cancer-prone family with Li Fraumeni syndrome. Radiation Research, 136, 236-240.
13. 2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes. Cancer Genetics and Cytogenetics, 14, 163-168.
14. SANFORD, K. K. and PARSHAD, R., 1990, Detection of cancer-prone individuals using cytogenetic response to X-rays. In Chromosomal Aberrations: Basic and Applied Aspects, edited by G. Obe and A. T. Natarajan (Berlin: Springer), pp. 113-120.
15. 2 chromatin radiosensitivity in predisposition to cancer. International Journal of Radiation Biology, 55, 963-981.
16. 2 phase X-irradiation, a marker of the ataxia-telangiectasia gene. Journal of the National Cancer Institute, 82, 1050-1054.
17. 60Co γ-irradiation in vitro. International Journal of Radiation Biology, 70, 521-527.
18. SCOTT, D., JONES, S. A., ELYAN, S. A. G., SPREADBOROUGH, A., COWAN, R. and RIBIERO, G., 1993, Identification of A-T heterozygotes. In Ataxia-telangiectasia, edited by R. A. Gatti and R. B. Painter (Berlin: Springer), pp. 101-116.
19. 2-phase lymphocytes as an indicator of cancer predisposition. Radiation Research, 145, 3-16.
20. SCOTT, D., SPREADBOROUGH, A., LEVINE, E. and ROBERTS, S. A., 1994, Genetic predisposition in breast cancer. Lancet, 344, 1444.
21. 2 chromosomal radiosensitivity in families with ataxia-telangiectasia. Human Genetics, 84, 15-18.
22. SHILOH, Y., PARSHAD., SANFOR, K. K. and JONES, G. M., 1986, Carrier detection in ataxia-telangiectasia. Lancet, i, 689-690.
23. SPROSTON, A. R. M., BOYLE, J. M., HEIGHWAY, J., BIRCH, J. M. and SCOTT, D., 1996, Fibroblasts from Li Fraumeni patients are resistant to low dose rate irradiation. International Journal of Radiation Biology, 70, 145-150.
24. TAYLOR, A. M. R., 1983, The effect of radiation on the chromosomes of patients with an unusual cancer susceptibility. In Radaition Induced Chromosome Damage in Man, edited by T. Ishikara and M. Sasaki (New York: A. R. Liss). pp. 166-199.
25. TAYLOR, A. M. R., HARNDEN, D. G., ARLETT, C. F., HARCOURT, S. A., LEHMANN, A. R., STEVENS, S. and BRIDGES, B. A., 1975, Ataxia-telangiectasia: a human mutation with abnormal radiation sensitivity. Nature, 258, 427-129.
26. WANG, L. CUI, Y., LORD, B. I., ROBERTS, S. A., POTTEN, C. S., HENDRY, J. H. and SCOTT, D., 1996, Gamma-ray-inducEd cell killing and chromosome abnormalities in bone marrow of p53 deficient mice. Radiation Research, 146, 159-266.
27. WEEKS, D. E., PATERSON, M. C., LANGE, K., ANDRIAS, B., DAVIS, R. C., VODER, F. and GATTI, R. A., 1991, Assessment of chronic γ radiosensitivity an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiation Research, 128, 90-99.
28. WILLIAMS, K. J., BOYLE, J. M., BIRCH, J. M., NORTON, J. D. and SCOTT, D., 1996, Cell cycle arrest defect in Li Fraumeni Syndrome: a mechanism of cancer predisposition? Oncogene, 14, 277-282.